| |
|
|
|
Intec Pharma Ord Shr  
|
|
5.35 0.1 (0.02%) |
04-20 16:00 |
|
Open: |
5.35 |
Pre close: |
5.25 |
Target:
|
7.02
|
|
High: |
5.445 |
Low: |
5.05 |
Resistance:
|
6.01
6.60
|
|
Volume: |
636,593 |
Market Cap: |
180M |
Support:
|
5.05
4.20
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
5.26
 |
MACD |
MACD(12,26):
|
-0.27 |
|
MA(20): |
5.89  |
Signal(12,26,9): |
-0.19 |
|
MA(100): |
6.00 |
Stochastic Oscillator |
%K(14,3):
|
13.98 |
|
MA(250): |
6.29 |
%D(3): |
12.37 |
|
Average Volume(K) |
3-Month: |
19497
|
52-Week |
High:
|
9.80 |
|
10-Days: |
78015 |
Low: |
4.80 |
|
RSI |
RSI(14):
|
34.90 |
Change(%): |
-2.7 |
|
Financials, Statistics and Valuation |
|
EPS |
0.000 |
Return on Equity (ttm) |
-71.4 |
Shares Out. (M) |
26.08 |
|
EPS Est. Current Year |
-1.670 |
Return on Assets (ttm) |
-65.2 |
Shares Float (M) |
26.08 |
|
EPS Est. Next Year |
-1.250 |
PEG Ratio |
0.00 |
% Held by Insiders |
0.00 |
|
EPS Est. Next Quarter |
-0.700 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
43.40 |
|
Forward EPS |
-1.050 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
504 |
|
Book Value (p.s.) |
2.330 |
EBITDA (p.s.) |
0.000 |
P/E |
0.00 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
2.30 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-22.13 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-16.29 |
P/CF |
-6.30 |
|
|
|
|
|
|
